Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.14M Buy
10,293
+5,903
+134% +$603K 1.46% 25
2022
Q3
$378K Hold
4,390
0.39% 48
2022
Q2
$413K Sell
4,390
-700
-14% -$62.1K 0.39% 49
2022
Q1
$417K Hold
5,090
0.33% 53
2021
Q4
$395K Hold
5,090
0.28% 62
2021
Q3
$382K Buy
+5,090
New +$387K 0.3% 61

Other funds holding MRK

swisspartners's MRK Position: Q4 2022 in Review

swisspartners increased its Merck (MRK) stake by 134% in Q4 2022, buying an estimated $603K and bringing the position to 10,293 shares worth $1.14M. The position accounts for 1.46% of the portfolio, ranked #25.

swisspartners first reported a position in MRK in Q3 2021 and has held it in 6 quarters since. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • swisspartners held 10,293 shares of Merck worth $1.14M as of Q4 2022.
  • swisspartners bought 5,903 Merck shares in Q4 2022, an estimated $603K.
  • Merck made up 1.46% of swisspartners's portfolio in Q4 2022, its #25 holding.
  • swisspartners first reported a position in Merck in Q3 2021 and has held it in 6 quarters since.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on swisspartners's 13F filing for Q4 2022, filed 14 Feb 2023.